Floseal: A Novel Application Technique For The Treatment Of Challenging Epistaxis

There were 24,719 emergency admissions for epistaxis in English NHS trusts from April 2017-April 2018.1 Epistaxis is initially managed with external nasal pressure and ice, then cautery, nasal packing, surgery or embolisation, in ascending order. There is growing evidence for Floseal use in anterior and posterior epistaxis. Floseal is a hydrophilic, biodegradable matrix haemosealant. The keyreported benefits of Floseal use include: high patient tolerance compared tonasal packing; good success rates; cost-effectiveness, as itavoids hospital admission; and it does not necessitate endoscopic insertion or general anaesthesia.